# Module 12: AI & Machine Learning in Hepatitis Diagnosis

> **Reference**: *Indonesian Journal of Computer Science*, Vol. 13, No. 3, 2024. ISSN: 2549-7286.

## 1. Introduction
Modern hepatology is increasingly leveraging Machine Learning (ML) to improve the accuracy, speed, and cost-effectiveness of hepatitis diagnosis. By analyzing clinical and laboratory findings (like age, gender, bilirubin, albumin, etc.), ML models can predict disease presence, severity, and patient outcomes.

---

## 2. Core Algorithms & Methodology

| Algorithm | Description | Performance Highlights |
| :--- | :--- | :--- |
| **Random Forest (RF)** | An ensemble method combining multiple decision trees. Handles complex interactions well. | Achieved **99.9% accuracy** in some UCI datasets; 94.06% in Egyptian HCV studies. |
| **Naive Bayes (NB)** | Probabilistic model based on Bayes' Theorem. Simple and scalable for real-time diagnostics. | Achieved ~90% accuracy; effective for early patient stratification. |
| **K-Nearest Neighbors (KNN)** | Classifies based on the similarity of feature vectors. | Accuracy varies (89.43% to 98.1%) depending on the value of 'K'. |
| **Support Vector Machines (SVM)** | Effective in high-dimensional spaces using kernel functions (Gaussian/Linear). | Gaussian RBF kernel reached **99.55% accuracy**. |
| **Artificial Neural Networks (ANN)** | Mimics biological neural processing. | High performance with ~96% accuracy and minimal Mean Square Error. |

---

## 3. Key Optimization Techniques
To reach high accuracy (90%+), researchers employ several critical preprocessing and optimization steps:

### A. Feature Selection
*   **Sequential Forward Selection (SFS)**: Identifies the most relevant diagnostic traits (e.g., specific blood markers).
*   **Ranker Search & Info-Gain**: Reduces dimensionality to focus on the most impactful data points.

### B. Data Imbalance & Missing Values
*   **SMOTE (Synthetic Minority Over-sampling Technique)**: Balances datasets where infected cases are much fewer than healthy cases.
*   **Mean/Mode Imputation**: Filling in missing clinical data to ensure model robustness.

### C. Hyperparameter Optimization
*   **Particle Swarm Optimization (PSO)**: Used to find the optimal 'K' in KNN, improving accuracy by ~2%.
*   **Random Search**: Tuning neural network parameters to boost performance beyond default settings.

---

## 4. Clinical Significance
*   **Early Detection**: ML allows for identification of hepatitis stages before severe symptoms manifest.
*   **Personalized Treatment**: By uncovering key diagnostic traits, these models help doctors choose tailored intervention strategies.
*   **Scalability**: High-throughput diagnostic tools enable screening in resource-limited environments.

---
[Back to Syllabus](../SYLLABUS.md)

